RCH Solutions, Inc, a leading provider of Bio-IT expertise exclusively for the Life Sciences, announces the introduction of new, cutting-edge AI services to revolutionize drug discovery and development. One of the first to embrace this industry paradigm shift toward AI and machine learning, the new AI services from RCH...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that the current Chief Technology Officer (CTO), Dr. Daniel Neil, is leaving the Company at the beginning of April after 7 years at BenevolentAI to relocate to be nearer his family. The Company is pleased to...
Ambiq, a technology leader in ultra-low power semiconductors to enable local AI on devices, partners with Smartaly, a designer of electronics to develop an energy-efficient and intelligent handheld electrocardiogram (ECG) monitor, tested in hospitals for widespread use.
Smartaly's handheld ECG relies on the Apollo3 SoC with built-in AI to monitor...
Microsoft Corp. is expanding its collaboration with NVIDIA to bring the power of generative AI, the cloud and accelerated computing to healthcare and life sciences organizations. The collaboration will bring together the global scale, security and advanced computing capabilities of Microsoft Azure with NVIDIA DGX Cloud and the NVIDIA Clara suite of computing platforms, software...
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®, with multiple clinical stage drug programs, announced the dosing of the first two patients in the Phase 1 clinical trial evaluating Lantern’s investigational new drug...
Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, and a global leader in using computational pathology to transform complex biomedical data...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced the launch of its Beta Program for the REM-I platform. Sites testing the REM-I platform are a selected number of leading academic institutions and medical centers in the U.S. and Europe including Newcastle...
Rapid Novor and MAbSilico partner to provide the world's first comprehensive AI-guided epitope mapping service. This service combines hydrogen-deuterium exchange mass spectrometry (HDX-MS) with advanced artificial intelligence (AI)-driven computational modeling. The result is a powerful platform capable of accurately predicting and validating binding epitopes for monoclonal antibodies. This approach...
Latest Investment Will Support the Democratization of Precision Medicine Through the Advancement of Novel Explainable AI Algorithms
Zephyr AI, Inc., a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to democratize precision medicine, announced it has successfully closed a $111 million Series A funding round...
Updates to Vertex AI Search, Healthcare Data Engine, and MedLM bring Google innovations to Cloud customers and ultimately improve patient care
Google Cloud announced several new solutions to help healthcare and life sciences organizations enable interoperability, build a better data foundation for their businesses, and deploy generative AI (gen AI)...
